Details for: SPOP
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 17.17rCSI 12.85%PRS 41.02
-
CSI 16.26rCSI 50.8%PRS 17.58
-
CSI 14.73rCSI 11.97%PRS 28.33
-
CSI 13.23rCSI 50.01%PRS 17.45
-
CSI 12.34rCSI 18.87%PRS 42.47
-
CSI 9.12rCSI 53.72%PRS 17.62
-
CSI 9.11rCSI 11.1%PRS 33.63
-
CSI 9.1rCSI 23.07%PRS 20.99
-
CSI 8.02rCSI 19.49%PRS 16.38
-
CSI 7.84rCSI 19.83%PRS 33.46
-
CSI 7.61rCSI 22.03%PRS 30.31
-
CSI 7.59rCSI 33.73%PRS 26.42
-
CSI 7.44rCSI 10.17%PRS 26.61
-
CSI 7.4rCSI 11.76%PRS 34.89
-
CSI 7.08rCSI 6.39%PRS 24.87
-
CSI 6.74rCSI 19.32%PRS 40.26
-
CSI 6.73rCSI 24.22%PRS 15.9
-
CSI 6.42rCSI 10.4%PRS 27.13
-
CSI 6.19rCSI 8.75%PRS 36.96
-
CSI 5.84rCSI 7.26%PRS 15.74
-
CSI 5.83rCSI 7.26%PRS 36.96
-
CSI 5.79rCSI 47.11%PRS 25.62
-
CSI 5.41rCSI 7.4%PRS 30.73
-
CSI 5.25rCSI 7.15%PRS 55.95
-
CSI 5.2rCSI 7.11%PRS 30
-
CSI 4.87rCSI 22.79%PRS 48.46
-
CSI 4.84rCSI 4.47%PRS 46.41
-
CSI 4.28rCSI 10.31%PRS 41.94
-
CSI 4.26rCSI 16.57%PRS 36.41
-
CSI 4.24rCSI 3.17%PRS 43.8
-
CSI 4.24rCSI 16.39%PRS 47.74
-
CSI 4.08rCSI 5.27%PRS 17.36
-
CSI 3.89rCSI 8.61%PRS 25.18
-
CSI 3.85rCSI 4.22%PRS 30.44
-
CSI 3.8rCSI 3.38%PRS 27.34
-
CSI 3.63rCSI 3.62%PRS 23.37
-
CSI 3.45rCSI 9.11%PRS 32.45
-
CSI 3.43rCSI 2.75%PRS 46.26
-
CSI 3.36rCSI 5.53%PRS 31.8
-
CSI 3.33rCSI 2.31%PRS 32.91
-
CSI 3.1rCSI 2.57%PRS 27.67
-
CSI 3.09rCSI 14.27%PRS 50.68
-
CSI 3.06rCSI 2.83%PRS 28.34
-
CSI 2.98rCSI 71.24%PRS 15.71
-
CSI 2.96rCSI 2.25%PRS 35.77
-
CSI 2.91rCSI 6.61%PRS 34.33
-
CSI 2.88rCSI 3.08%PRS 25.22
-
CSI 2.86rCSI 69.02%PRS 16.56
-
CSI 2.86rCSI 2.4%PRS 41.67
-
CSI 2.84rCSI 2.21%PRS 39.65
-
CSI 2.77rCSI 2.39%PRS 38.64
-
CSI 2.73rCSI 2.85%PRS 28.02
-
CSI 2.7rCSI 29.53%PRS 45.21
-
CSI 2.67rCSI 1.92%PRS 37.05
-
CSI 2.65rCSI 2.78%PRS 25.48
-
CSI 2.65rCSI 15.18%PRS 38.34
-
CSI 2.64rCSI 3.75%PRS 25.38
-
CSI 2.63rCSI 1.95%PRS 23.45
-
CSI 2.61rCSI 2.4%PRS 32.43
-
CSI 2.61rCSI 4.98%PRS 42.03
-
CSI 2.61rCSI 2.07%PRS 18.9
-
CSI 2.61rCSI 4.66%PRS 25.49
-
CSI 2.57rCSI 2.08%PRS 27.43
-
CSI 2.45rCSI 2.31%PRS 28.49
-
CSI 2.24rCSI 2.29%PRS 38.09
-
CSI 2.23rCSI 3.56%PRS 23.31
-
CSI 2.18rCSI 4.97%PRS 23.46
-
CSI 2.16rCSI 8.72%PRS 25.7
-
CSI 2.16rCSI 8.81%PRS 27.73
-
CSI 2.15rCSI 2.21%PRS 46.27
-
CSI 2.14rCSI 1.49%PRS 37.63
-
CSI 2.14rCSI 6.31%PRS 31.65
-
CSI 2.13rCSI 12.26%PRS 32.52
-
CSI 2.12rCSI 1.65%PRS 26.64
-
CSI 2.11rCSI 2.82%PRS 34.35
-
CSI 2.11rCSI 3.33%PRS 27.55
-
CSI 2.09rCSI 3.2%PRS 34.84
-
CSI 2.09rCSI 4.91%PRS 37.53
-
CSI 2.08rCSI 2.88%PRS 35.28
-
CSI 2.02rCSI 3.57%PRS 26.61
-
CSI 2.01rCSI 2.57%PRS 26.06
-
CSI 1.99rCSI 1.92%PRS 28.17
-
CSI 1.99rCSI 9.98%PRS 35.7
-
CSI 1.97rCSI 16.96%PRS 16.61
-
CSI 1.94rCSI 2.48%PRS 26.14
-
CSI 1.93rCSI 6.18%PRS 23.7
-
CSI 1.91rCSI 2.81%PRS 25.33
-
CSI 1.9rCSI 1.95%PRS 42.37
-
CSI 1.89rCSI 1.56%PRS 25.98
-
CSI 1.83rCSI 2.63%PRS 21.51
-
CSI 1.76rCSI 3.86%PRS 35.84
-
CSI 1.75rCSI 1.54%PRS 35.43
-
CSI 1.75rCSI 2.73%PRS 54.93
-
CSI 1.75rCSI 2.78%PRS 23
-
CSI 1.74rCSI 2.22%PRS 31.28
-
CSI 1.74rCSI 1.21%PRS 28.82
-
CSI 1.72rCSI 5.57%PRS 31.78
-
CSI 1.69rCSI 3.4%PRS 20.37
-
CSI 1.68rCSI 4.11%PRS 26.14
-
CSI 1.68rCSI 2.88%PRS 35.9
-
CSI 0.1rCSI 0.4%PRS 38.9%
-
CSI 0.1rCSI 1.0%PRS 48.5%
-
CSI 0.2rCSI 1.4%PRS 47.5%
-
CSI 0.2rCSI 5.4%PRS 48.4%
-
CSI 0.3rCSI 3.8%PRS 60.1%
-
CSI 0.3rCSI 1.9%PRS 27.1%
-
CSI 0.3rCSI 3.1%PRS 56.9%
-
CSI 0.3rCSI 1.5%PRS 49.7%
-
CSI 0.3rCSI 1.0%PRS 28.2%
-
CSI 0.3rCSI 0.8%PRS 42.8%
-
CSI 0.3rCSI 0.6%PRS 34.5%
-
CSI 0.3rCSI 0.5%PRS 41.6%
-
CSI 0.3rCSI 1.8%PRS 54.3%
-
CSI 0.4rCSI 5.6%PRS 27.8%
-
CSI 0.4rCSI 2.3%PRS 22.0%
-
CSI 0.4rCSI 2.5%PRS 60.1%
-
CSI 0.4rCSI 1.3%PRS 19.4%
-
CSI 0.4rCSI 0.6%PRS 29.0%
-
CSI 0.4rCSI 2.8%PRS 27.8%
-
CSI 0.4rCSI 1.7%PRS 43.5%
-
CSI 0.4rCSI 6.1%PRS 22.4%
-
CSI 0.4rCSI 1.0%PRS 39.0%
-
CSI 0.4rCSI 1.9%PRS 43.7%
-
CSI 0.5rCSI 1.4%PRS 53.4%
-
CSI 0.5rCSI 1.2%PRS 22.9%
-
CSI 0.5rCSI 3.6%PRS 28.6%
-
CSI 0.5rCSI 2.3%PRS 29.0%
-
CSI 0.5rCSI 2.5%PRS 42.7%
-
CSI 0.5rCSI 2.9%PRS 65.1%
-
CSI 0.5rCSI 2.6%PRS 36.4%
-
CSI 0.5rCSI 11.0%PRS 24.2%
-
CSI 0.5rCSI 11.0%PRS 22.9%
-
CSI 0.6rCSI 1.6%PRS 21.6%
-
CSI 0.6rCSI 3.8%PRS 28.3%
-
CSI 0.6rCSI 0.7%PRS 20.3%
-
CSI 0.6rCSI 0.8%PRS 38.1%
-
CSI 0.6rCSI 2.5%PRS 56.0%
-
CSI 0.6rCSI 2.1%PRS 67.2%
-
CSI 0.6rCSI 0.7%PRS 26.4%
-
CSI 0.6rCSI 3.5%PRS 38.7%
-
CSI 0.6rCSI 1.2%PRS 51.9%
-
CSI 0.6rCSI 3.4%PRS 17.2%
-
CSI 0.6rCSI 0.7%PRS 50.1%
-
CSI 0.6rCSI 0.5%PRS 46.4%
-
CSI 0.6rCSI 2.8%PRS 25.9%
-
CSI 0.6rCSI 2.5%PRS 51.2%
-
CSI 0.6rCSI 1.6%PRS 26.5%
-
CSI 0.7rCSI 2.1%PRS 19.1%
-
CSI 0.7rCSI 1.2%PRS 34.7%
-
CSI 0.7rCSI 1.8%PRS 40.0%
-
CSI 0.7rCSI 1.7%PRS 25.5%
-
CSI 0.7rCSI 1.9%PRS 25.6%
-
CSI 0.7rCSI 2.7%PRS 33.8%
-
CSI 0.7rCSI 2.2%PRS 39.0%
-
CSI 0.7rCSI 2.0%PRS 42.5%
-
CSI 0.7rCSI 1.5%PRS 36.9%
-
CSI 0.7rCSI 1.6%PRS 20.7%
-
CSI 0.8rCSI 3.3%PRS 24.4%
-
CSI 0.8rCSI 2.0%PRS 27.5%
-
CSI 0.8rCSI 5.9%PRS 17.9%
-
CSI 0.8rCSI 1.2%PRS 28.0%
-
CSI 0.8rCSI 1.5%PRS 22.8%
-
CSI 0.8rCSI 1.5%PRS 52.4%
-
CSI 0.8rCSI 3.6%PRS 19.1%
-
CSI 0.8rCSI 0.7%PRS 33.9%
-
CSI 0.8rCSI 1.7%PRS 37.6%
-
CSI 0.9rCSI 2.5%PRS 26.4%
-
CSI 0.9rCSI 0.7%PRS 31.9%
-
CSI 0.9rCSI 1.4%PRS 21.1%
-
CSI 0.9rCSI 0.6%PRS 33.9%
-
CSI 0.9rCSI 1.2%PRS 31.3%
-
CSI 0.9rCSI 1.4%PRS 32.4%
-
CSI 0.9rCSI 2.0%PRS 19.7%
-
CSI 0.9rCSI 0.7%PRS 29.2%
-
CSI 0.9rCSI 2.1%PRS 40.1%
-
CSI 1.0rCSI 0.8%PRS 30.4%
-
CSI 1.0rCSI 2.0%PRS 25.9%
-
CSI 1.0rCSI 1.4%PRS 31.0%
-
CSI 1.0rCSI 2.3%PRS 19.5%
-
CSI 1.0rCSI 2.5%PRS 25.1%
-
CSI 1.0rCSI 1.0%PRS 29.0%
-
CSI 1.0rCSI 3.9%PRS 25.2%
-
CSI 1.0rCSI 2.4%PRS 44.8%
-
CSI 1.0rCSI 0.8%PRS 25.7%
-
CSI 1.0rCSI 3.6%PRS 23.4%
-
CSI 1.1rCSI 3.4%PRS 36.3%
-
CSI 1.1rCSI 2.1%PRS 28.2%
-
CSI 1.1rCSI 2.2%PRS 28.3%
-
CSI 1.1rCSI 4.2%PRS 43.8%
-
CSI 1.1rCSI 1.7%PRS 44.9%
-
CSI 1.1rCSI 1.6%PRS 35.5%
-
CSI 1.1rCSI 1.1%PRS 29.2%
-
CSI 1.1rCSI 2.5%PRS 30.9%
-
CSI 1.1rCSI 3.8%PRS 20.0%
-
CSI 1.1rCSI 1.9%PRS 51.7%
-
CSI 1.1rCSI 2.7%PRS 30.3%
-
CSI 1.2rCSI 4.2%PRS 44.2%
-
CSI 1.2rCSI 1.9%PRS 21.2%
-
CSI 1.2rCSI 2.8%PRS 38.4%
-
CSI 1.2rCSI 1.8%PRS 27.5%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 2502911978
Symbol: SPOP_HUMAN
Name: HIB homolog 1
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9414087
Title: Identification of a novel nuclear speckle-type protein, SPOP.
PubMed ID: 9414087
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 14528312
Title: Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases.
PubMed ID: 14528312
DOI: 10.1038/ncb1056
PubMed ID: 15240113
Title: Daxx-mediated transcriptional repression of MMP1 gene is reversed by SPOP.
PubMed ID: 15240113
PubMed ID: 15897469
Title: Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase.
PubMed ID: 15897469
PubMed ID: 16651542
Title: Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus.
PubMed ID: 16651542
DOI: 10.1242/dev.02370
PubMed ID: 16740475
Title: A hedgehog-induced BTB protein modulates hedgehog signaling by degrading Ci/Gli transcription factor.
PubMed ID: 16740475
PubMed ID: 16524876
Title: BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
PubMed ID: 16524876
PubMed ID: 22085717
Title: Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
PubMed ID: 22085717
PubMed ID: 36791496
Title: SPOP is essential for DNA replication licensing through maintaining translation of CDT1 and CDC6 in HaCaT cells.
PubMed ID: 36791496
PubMed ID: 37622993
Title: SPOP targets the immune transcription factor IRF1 for proteasomal degradation.
PubMed ID: 37622993
DOI: 10.7554/elife.89951
PubMed ID: 37796126
Title: Ubiquitin E3 ligase SPOP is a host negative regulator of enterovirus 71-encoded 2A protease.
PubMed ID: 37796126
DOI: 10.1128/jvi.00786-23
PubMed ID: 38018242
Title: SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1alpha.
PubMed ID: 38018242
DOI: 10.1002/jmv.29254
PubMed ID: 19818708
Title: Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligases.
PubMed ID: 19818708
PubMed ID: 22632832
Title: Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase.
PubMed ID: 22632832
PubMed ID: 32109420
Title: De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
PubMed ID: 32109420
Sequence Information:
- Length: 374
- Mass: 42132
- Checksum: EE5F4C5CF6FD09DC
- Sequence:
MSRVPSPPPP AEMSSGPVAE SWCYTQIKVV KFSYMWTINN FSFCREEMGE VIKSSTFSSG ANDKLKWCLR VNPKGLDEES KDYLSLYLLL VSCPKSEVRA KFKFSILNAK GEETKAMESQ RAYRFVQGKD WGFKKFIRRD FLLDEANGLL PDDKLTLFCE VSVVQDSVNI SGQNTMNMVK VPECRLADEL GGLWENSRFT DCCLCVAGQE FQAHKAILAA RSPVFSAMFE HEMEESKKNR VEINDVEPEV FKEMMCFIYT GKAPNLDKMA DDLLAAADKY ALERLKVMCE DALCSNLSVE NAAEILILAD LHSADQLKTQ AVDFINYHAS DVLETSGWKS MVVSHPHLVA EAYRSLASAQ CPFLGPPRKR LKQS